Soren Acquisition Corp. Class A Ordinary Shares (SORN)
Key Financials
| Current Price | $10.04 |
| Market Cap | $344M |
| P/E Ratio | — |
| ROE | —% |
| Dividend Yield | 0% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At the 2026-10-16 close of $10.06, Soren Acquisition is a 2025-formed shell with a $344.2M market cap, no reported revenue in its filed periods, and no disclosed merger target in the data I have. In fiscal Q2 2026, the quarter ended 2026-06-30, net income was $2.0M; in fiscal Q1 2026, the quarter ended 2026-03-31, net income was $1.7M, but revenue was n/a in both, and diluted EPS was n/a. That is not enough to judge business quality. There is no visible competitive moat because there is no operating business yet; the stated healthcare focus is only an intention. Financial health is mixed: FairStock shows D/E of 1.54 and a Piotroski F-Score of 2/9, which is weak, while its Altman Z-score of 682.48 is extreme and less meaningful for a shell. Valuation offers little Graham-style comfort: P/E and EPS are N/A, P/B is 201.20, dividend yield is 0.00%, and the price sits within the 52-week range of $9.81-$10.88. Growth cannot be measured because revenue growth and profit growth are N/A. FairStock's Lynch category is none, since only 0 years of filed results exist versus the 3 needed. The key event is a real merger with a healthcare business, plus deal terms and cash/redemption details. Until then, this is a speculative blank check, not a proven compounder, and I see no margin of safety in the reported numbers.
In plain English: Soren Acquisition is a company set up in 2025 to merge with a healthcare business; it has no reported revenue in its latest two filed quarters. It reported net income of $2.0 million in the quarter ended June 30, 2026 and $1.7 million in the quarter ended March 31, 2026, but there is no clear operating business to judge. At $10.06, the price looks expensive compared with the company's recorded net worth, and the business looks unproven rather than strong.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-16 close · note generated 2026-10-20 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer